Trade BioNTech ^BNTX

BioNTech (NASDAQ:BNTX) Research Coverage Started at Argus - Stock Observer

BioNTech (NASDAQ:BNTX) CEO Sells $2,300,640.00 in Stock - Markets Daily

BioNTech (NASDAQ:BNTX) CEO Sells 27,000 Shares of Company Stock - Markets Daily

BioNTech (NASDAQ: BNTX) CEO sells all direct shares under trading plan - Stock Observer

Moderna stock jumps on planned national cancer vaccine effort

Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up

12,163 BioNTech SE Sponsored ADR $BNTX Shares Sold by Crocodile Capital Partners GmbH - Daily Political

Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $7,000,560.00 in Stock - Daily Political

BioNTech (NASDAQ:BNTX) Now Covered by Argus

BioNTech (NASDAQ:BNTX) Stock Picked Up by Analysts at Argus - Zolmax

Is BioNTech (BNTX) Undervalued On Pipeline Promise Despite Revenue Of €2,650.0 Million And Losses?

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Stock Now Rated "Moderate Buy" by Wall Street Analysts - Daily Political

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 24,000 Shares of Stock

Is BioNTech (NasdaqGS:BNTX) Overvalued As Sales Face A Reset?

BNTX Maintained by Morgan Stanley -- Price Target Lowered to $11

BioNTech (NASDAQ: BNTX) CEO sells 93,000 shares under preplanned deal - Markets Daily

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 72,000 Shares

Moderna Is Up 545% in 2026: Take Profits Now, or Keep Buying?

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 72,000 Shares of Company Stock - Stock Observer

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Stock Has Average Price Target of $126.00 According to Brokerages - Markets Daily

Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up

Moderna Surges 8% as Full Melanoma Readout Nears; BioNTech Ticks Up, Pfizer Slips

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Stock Has Consensus Target Price of $126.00

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 17,000 Shares

Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water

BioNTech (NASDAQ:BNTX) CEO Sells $2,664,630.00 in Stock - Markets Daily

BioNTech (NASDAQ:BNTX) CEO Sells $3,347,980.00 in Stock - Stock Observer

BioNTech CEO sold shares under plan - Stock Observer

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 32,000 Shares of Stock

BioNTech Closes Manufacturing Sites in Germany and Singapore Amidst Failed Sales, ETPharma

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 27,000 Shares

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 34,000 Shares

How New Lung Cancer Data And Updated COVID Shot At BioNTech (BNTX) Has Changed Its Investment Story

Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)

BioNTech (NasdaqGS:BNTX) Stock May Look Fully Valued On Fresh Lung Cancer Trial Data

BioNTech co-founders name new pharmaceutical company 'Arife' - Türkiye News

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 30,000 Shares

Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?

BioNTech (NASDAQ:BNTX) Stock: Insider Ugur Sahin Sells 39,000 Shares - Stock Observer

BioNTech (NASDAQ:BNTX) CEO Sells 46,000 Shares of Stock

Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $4,633,120.00 in Stock - Zolmax

BioNTech (NASDAQ:BNTX) CEO Sells 33,000 Shares

Moderna Adds Another 5% and Is Up 500% in 2026. Can MRNA Stock Continue the Melt-Up?

Biontech Se (BNTX) - Insider Monkey

Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher

BioNTech (BNTX) Could Be 19% Undervalued On Vaccine Approval And Phase 3 Data

Ugur Sahin Sells 34,000 Shares of BioNTech (NASDAQ:BNTX) Stock

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 30,000 Shares - Daily Political

Did Survival Trial Win Just Shift BioNTech (BNTX) Investment Narrative?

Is BioNTech (BNTX) Too Pricey for Its Current Sales Base?

BioNTech (NASDAQ:BNTX) CEO Sells $3,280,660.00 in Stock

Ugur Sahin Sells 15,000 Shares of BioNTech (NASDAQ:BNTX) Stock

BioNTech (NASDAQ:BNTX) CEO Sells 34,000 Shares of Stock - Stock Observer

BioNTech's Lung Cancer Drug Shows Signs of a Major Breakthrough

BioNTech and OncoC4 report median OS data from RESERVE-003 Phase III trial

Brokerages Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Target Price at $127.44 - Zolmax

Insider Selling: BioNTech (NASDAQ:BNTX) CEO Sells $4,361,850.00 in Stock

BioNTech (NASDAQ:BNTX) CEO Ugur Sahin Sells 41,000 Shares of Stock - Stock Observer

BioNTech (NASDAQ:BNTX) Shares Gap Up - What's Next?

BioNTech lung cancer drug extends survival versus chemotherapy

BioNTech's Gotistobart Nearly Doubles Median Overall Survival In Previously Treated Squamous NSCLC

Analysts Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) PT at $127.44 - Daily Political

Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Moderna share price jumps as Oppenheimer upgrades stock

Pfizer shares sink on lower COVID revenue prospects

5 Stocks to Fall in Love with this Valentines Day

Stocks make further gains as oil bounce carries on

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk